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STANDARD OPERATION FOR NSCLC IN JAPAN
The Japan Lung Cancer Society published General
Rules for Clinical and Pathological Record of Lung Cancer,
including the definition of standard operations for lung cancer
by stage.1 The standard operation for stage I NSCLC is
defined as lung resection with systematic nodal dissection in
Japan. Suitable lung resection and lymph node dissection,
results of surgery for stage I NSCLC, subclassification of
stage I NSCLC, and limited surgery are discussed.
LUNG RESECTION
Lobectomy is required at least for the standard opera-
tion for stage I NSCLC. Pneumonectomy is done very rarely
but should be performed for lung cancer invading both lobes
at the hilum of the lung. Adaptation of limited resection
including segmentectomy and wedge resection of the lung to
stage I is considered controversial at present because the
results of the study reported by Lung Cancer Study Group in
1995 showed that limited resection did not confer improved
perioperative morbidity, mortality, or late postoperative im-
proved pulmonary function. Instead limited resection resulted
in a higher death rate and a locoregional recurrence rate in the
limited resection group.2
LYMPH NODE DISSECTION
The Japan Lung Cancer Society recommends system-
atic nodal dissection consisting of lymph nodes in the upper
mediastinum, subcarina, and lower mediastinum. The field is
similar to that recommended by Cahan et al.3 in their article
entitled “Radical Pneumonectomy,” published in 1951. For
stage I lung cancer, the location of lymph node metastases is
related to the lobar location of the primary tumor. For
example, if there is no upper mediastinal lymph node metas-
tasis in the case of upper lobe stage I lung cancer, subcarinal
or lower mediastinal lymph node metastasis is extremely rare.
Conversely, if lymph node metastasis is found in the subca-
rina and lower mediastinum of lower lobe stage I lung cancer,
upper mediastinal lymph node metastasis is very rare.4 Ac-
cording to those results, lobe-specific extent of systematic
nodal dissection for stage I NSCLC is becoming a de facto
standard in Japan recently.
This de facto standard in Japan is similar to radical
lobectomy described in the article entitled “Radical Lobec-
tomy” reported by Cahan5 in 1960. Cahan’s insight was con-
firmed by Japanese retrospective studies.
RESULTS OF SURGERY FOR STAGE I NSCLC
The Japanese Joint Committee of Lung Cancer Registry
sent a questionnaire to 320 Japanese institutions regarding the
prognosis and clinicopathological profiles of patients who
underwent resection for primary lung neoplasms in 1994. The
Committee compiled the data for 7408 patients from 303
institutions (94.7%). Among these, 6644 patients with
NSCLC were studied in terms of prognosis.6 The 5-year
survival rate of the entire group was 52.6%. The 5-year
survival rate of pathological stage IA was 79.5%, stage IB
was 60.1%, and stage IIA was 59.9%. However, the 5-year
survival rates by clinical stage were as follows: 72.1% for
stage IA and 49.9% for IB. In the practical aspects for preoper-
ative evaluation, only the 5-year survival rate of clinical stage IA
over 50% is acceptable for the choice of standard procedure with
lung resection and systematic lymph node dissection (Table 1).
SUBCLASSIFICATION OF STAGE I NSCLC
The 72.1% 5-year survival rate for stage I NSCLC
means that many patients with this early-stage disease are still
not cured. The reason why the prognosis of clinical stage I
NSCLC is not better after surgery is the presence of micro-
metastasis in lymph nodes detected by pathological exami-
nation. In the case of clinical T1 lung cancer, 16.6% of
patients had mediastinal lymph node metastasis and another
9.5% of patients had metastasis in the pulmonary hilum. Even
in the case of lung cancer with less than a 2-cm diameter,
11.5% of them had mediastinal lymph node metastasis and
another 8.0% had hilar lymph node metastasis.4 Therefore, if
we can cure the patients with hilar lymph node metastasis by
complete systematic lymph node dissection, the 5-year sur-
vival rate would be 83.4% in the case of T1 lung cancer and
88.5% in lung cancer of less than 2 cm in diameter. Com-
puted tomography (CT) was introduced to detect early-stage
lung cancer in Japan.7 CT screening detected many tiny lesions
with ground-glass attenuation that could not be detected by
conventional chest radiography. Forty-eight patients with
peripheral lung cancer with a diameter less than 1 cm were
operated on at the National Cancer Center. The clinicopath-
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ological features of these lung cancers were analyzed accord-
ing to three types of appearance on high-resolution CT:
nonsolid ground-glass opacity (GGO) type (n 19), partially
solid GGO type (n  9), and solid type (n  20). Lymph
node involvement was seen in only three patients with solid
lesions (N1 in two patients, N2 in one patient)8 (Table 2).
Okada et al.9 showed a good 5-year survival rates of lung
cancer with a diameter of less than 1 cm and 1 to 2 cm: 100%
and 83.5%, respectively (Table 3). Lung cancer with a diam-
eter less than 1 cm is still rare, but 1 to 2 cm lung cancers are
very common in Japan. Therefore, T1 lung cancer should be
divided into two groups: less than 2 cm in diameter and 2 to
3 cm. This subclassification will be practical and convenient
for modification of surgical procedures.
LIMITED SURGERY AS A SUBJECT OF FUTURE
CLINICAL TRIALS
Okada et al.10 reported that tumor size is an indepen-
dent and significant prognostic factor and important for plan-
ning surgical treatment (Table 4). They stated that although
lobectomy should be chosen for patients with a tumor greater
than 30 mm in diameter, further investigation is required for
tumors 21 to 30 mm in diameter. Segmentectomy should, as
a lesser anatomic resection, be distinguished from wedge
resection and might be acceptable for patients with a tumor
20 mm or less in diameter without nodal involvement. It
would be appropriate to conduct a randomized, controlled trial
of lobectomy versus segmentectomy for the tumors 20 mm or
less in diameter. The protocol would be similar in design to
the protocol reported by the Lung Cancer Study Group.
However, limited resection should be specified as only ana-
tomical segmentectomy.
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TABLE 1. Five-Year Survival Rate by Pathological and
Clinical Stage
Pathological Stage Clinical Stage
Stage
5-yr Survival
Rate, %
No. of
Cases
5-yr Survival
Rate, %
No. of
Cases
IA 79.5 2009 72.1 2423
IB 60.1 1418 49.9 1542
IIA 59.9 232 48.7 150
IIB 42.2 757 40.6 746
IIIA 29.8 1250 35.8 1270
IIIB 19.3 719 28.0 366
IV 20.0 259 20.8 147
Based on Goya et al.6
TABLE 2. Lymph Node Metastasis by Clinicopathological
Type of Lung Cancer with a Diameter Less Than 1 cm
GGO Partial Solid Solid Total
N0 19 9 17 45
N1 0 0 2 2
N2 0 0 1 1
Total 19 9 20 48
GGO, ground-glass opacity.
TABLE 3. Survival Rate by Size of Primary Tumor
<10 mm
11 to
<20 mm
21 to
<30 mm >31 mm
No. of patients 50 273 368 581
5-yr survival rate 100 83.5 76.5 57.9
TABLE 4. Five-Year Survival by Procedure for T1 Lung
Cancer
<20 mm 21 to <30 mm >31 mm
Lobectomy 92.4 87.4 81.3
Segmentectomy 96.7 84.6 62.9
Wedge resection 85.7 39.4 0
Limited lobectomy 167/323 (52%) 156/949 (16%)
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